RAD December 2020 Abstracts - Page 3

#348 - Interventions to Improve Primary Care Provider Management of Atopic Dermatitis: A Systematic Review

Emily A. Croce, MSN, APRN, CPNP-PC, PhD Student; Fabiana Castro Porto Silva Lopes, MD; Maria Anna Leszczynska, MD; Jennifer Ruth, MD; Jonathan I. Silverberg, MD, PhD, MPH

#350 - Rapid Itch Improvement in Children With Severe Atopic Dermatitis Treated With Dupilumab: A Phase 3 Subset Analysis

Gil Yosipovitch, Jonathan I. Silverberg, Jashin J. Wu, Zhen Chen, Randy Prescilla, Ana B. Rossi, Dimittri Delevry 

#351 - Dupilumab Induces Rapid and Sustained Improvement in Clinical Signs in Children With Severe Atopic Dermatitis

Amy S. Paller, Elaine C. Siegfried, Peter D. Arkwright, Rui Huang, Haixin Zhang, Noah A. Levit, Karli Rosner, Ana B. Rossi 

#352 - Dupilumab Treatment Provides Improvements in Signs of Atopic Dermatitis (AD) at Week 100 in Adult Patients With Moderate-to-Severe AD Who Did Not Achieve ≥75% Reduction in Eczema Area and Severity Index at Week 16

April Armstrong, Andrew Blauvelt, Eric L Simpson, Zhen Chen, Marius Ardeleanu, Ana B. Rossi, Paul Tomondy

#353 - The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study

Melinda J. Gooderham, MSc, MD, Leon H. Kircik, MD, Matthew Zirwas, MD, Mark Lee, MD, Steven E. Kempers, MD, Zoe D. Draelos, MD, Laura K. Ferris, MD, PhD, Terry M. Jones, MD, Etienne Saint-Cyr Proulx, MD, Robert Bissonnette, MD, Neal Bhatia, MD, Scott T. Guenthner, MD, Robert A. Koppel, MD, Howard Welgus, MD, Charlotte Merritt, MBA, Meg Elias, BSN, Lynn Navale, MS, Robert C. Higham, MPAS, PA-C, Michael Droege, PhD, David R. Berk, MD

#355 - Clinical tailoring of baricitinib 2-mg in atopic dermatitis: baseline body surface area and rapid onset of action identifies response at Week 16

Jonathan I. Silverberg, Mark Boguniewicz, Jill Waibel, Jamie Weisman, Lindsay Strowd, Luna Sun, Yuxin Ding, Orin Goldblum, Fabio P. Nunes, Eric L. Simpson 

#356 - A Survey of Adults with Atopic Dermatitis Reveals a Need For Better Symptom Control

Shari J. Dermer, PhD, Piyali Chatterjee-Shin, BS, Anjali Mehra, MD; Pan Chen, PhD; Katie S. Lucero, PhD 

#357 - Dupilumab Treatment Improves Health-Related Quality of Life in Children Aged ≥6 to <12 Years With Severe Atopic Dermatitis

Alan D. Irvine, Mette Deleuran, Amy Praestgaard, Dimittri Delevry, Ana B. Rossi

#358 - Rates of Cardiovascular Events Among Patients With Moderate-to-Severe Atopic Dermatitis: A Retrospective Cohort Study 

Monique M. Hedderson, Fei Xu, Charles P. Quesenberry, Sneha Sridhar, Jamie Geier, Adina R. Lemeshow

#359 - Economic Impact of Abrocitinib Monotherapy and Combination Therapy in Patients With Moderate-to-Severe Atopic Dermatitis: Results From JADE MONO-2 and JADE COMPARE

Melinda J. Gooderham, Chia-Yu Chu, Ricardo Rojo, Hernan Valdez, Pinaki Biswas, Michael C. Cameron, Claire Feeney, Gerardo A. Encinas, Kathleen Peeples-Lamirande, Joseph C. Cappelleri, Daniela E. Myers, Marco DiBonaventura 

#360 - A Phase 3 Study to Investigate the Efficacy and Safety of Abrocitinib and Dupilumab in Comparison With Placebo in Adults With Moderate-to-Severe Atopic Dermatitis

Diamant Thaçi, Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Carle Paul, Rodney Sinclair, Andrew E. Pink, Yoko Kataoka, Chia-Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernan Valdez 

© 2023 The Foundation for Dermatology Education.
The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.